Network meta-analyses in comparative effectiveness research: an interview with Ulf Staginnus

Written by The Evidence Base
Artificial intelligence and machine learning Events coverage Interviews Methodology Oncology and hematology Stakeholder engagement

In this feature, we discuss Ipsen’s (Paris, France) use of systematic reviews and network meta-analyses in comparative effectiveness research with its Senior Vice President of Global Market Access and Pricing, Ulf Staginnus. At the ISPOR Europe 2019 (2—6 November; Copenhagen, Denmark) meeting, Ipsen (Paris, France) representatives presented two key studies with the aim of increasing stakeholders’ understanding of treatment pathways, demonstrating value to payers and positively impact patient outcomes. One study involved an assessment of the budget impact of long-acting somatostatin analogues (LA-SSAs) in the treatment of acromegaly and gastroenteropancreatic neuroendocrine tumors, considering attributes related to drug delivery of LA-SSAs...

To view this content, please register now for access

It's completely free